Arcosa (ACA) EBIT (2017 - 2026)

Arcosa (ACA) has 10 years of EBIT data on file, last reported at $47.1 million in Q1 2026.

• Quarterly EBIT rose 14.88% year-over-year to $47.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $333.2 million (up 79.91% YoY) and the FY2025 annual result came in at $341.9 million, up 73.03% from the prior year.
• EBIT retreated to $47.1 million in Q1 2026 per ACA's latest filing, from $79.0 million in the prior quarter.
• The five-year high for EBIT was $208.1 million in Q4 2022, with the low at $33.8 million in Q3 2024.
• Average EBIT over 5 years is $66.9 million, with a median of $51.0 million recorded in 2023.
• Year-over-year, EBIT surged 1233.97% in 2022 and tumbled 79.43% in 2023.
• Arcosa's EBIT stood at $208.1 million in 2022, then plunged by 79.43% to $42.8 million in 2023, then increased by 0.93% to $43.2 million in 2024, then jumped by 82.87% to $79.0 million in 2025, then tumbled by 40.38% to $47.1 million in 2026.
• Business Quant data shows ACA's EBIT at $47.1 million in Q1 2026, $79.0 million in Q4 2025, and $112.3 million in Q3 2025.